Listing & Compliance Notices

T2 Biosystems, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).

“June 20, 2023, the Company received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last ten consecutive business days, the bid price for the Company’s common stock had closed below the minimum $0.10 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stock Rule”). Pursuant to a prior non-compliance letter from Nasdaq dated November 22, 2022, the Company received a letter from Nasdaq indicating that, for the last thirty consecutive business day”

ATOSSA THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1)).

“June 21, 2023, Atossa Therapeutics, Inc. (the “Company”) received formal notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer complies with Nasdaq Listing Rule 5605(b)(1), which requires a board of directors comprised of a majority of independent directors (the “Rule”), due to the appointment of Greg Weaver, formerly an independent director, as the Company’s Executive Vice President and Chief Financial Officer. The Staff’s notice has no immediate effect on the listing of the Company’s common stock, which the”

HeartSciences Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).

“June 20, 2023, the Company received a delist determination letter from the Staff advising the Company that the Staff had determined that the Company did not meet the terms of the extension by the June 19, 2023 deadline. The Company intends to timely appeal the Staff's delisting determination by submitting a hearing request to the Nasdaq Hearings Panel (the “Panel”), which request will automatically stay the delisting of the Company's securities by the Staff at least until the hearing process concludes and any extension granted by the Panel expires. At the Panel hearing, the Company intends to”

Lexaria Bioscience Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“June 22, 2023, Lexaria Bioscience Corp. (the “Company”) received a letter (the “Bid Price Deficiency Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Bid Price Deficiency Notice has no immediate effect on the listing of the Company’s common stock, and the Company’s common stock continues to trade on the Nasdaq Capital Market un”

SALEM MEDIA GROUP, INC. /DE/ received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“June 23, 2023, Salem Media Group, Inc. (the “ Company ”) received a letter (the “ Letter ”) from The Nasdaq Stock Market (“ Nasdaq ”) informing the Company that its common stock, par value $0.01 per share (the “ Common Stock ”), failed to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5450(a)(1) based upon the closing bid price of the Common Stock for the 32 consecutive business days prior to the date of the Letter. The Letter also indicated that the Company has a compliance period of 180 calendar days in which to rega”

Growth for Good Acquisition Corp received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“June 13, 2023, The Growth for Good Acquisition Corporation (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Listing Rule 5452(b)(C), due to the Company’s failure to maintain the minimum of $1,000,000 in aggregate market value of its outstanding warrants. The Notice is only a notification of deficiency, not of imminent delisting. The Notice states that the Company has until July 28, 2023 to submit a plan to achieve and sustain complianc”

Jaguar Global Growth Corp I received a nasdaq noncompliance notice notice regarding market value (rules 5452(b)(C)).

“June 14, 2023, JGGC received a notice (the “ Notice ”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that since JGGC’s aggregate market value of its outstanding warrants was less than $1 million, JGGC was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C) (the “ Listing Rule ”), which requires JGGC to maintain an aggregate market value of its outstanding warrants of at least $1 million. The Notice states that JGGC has 45 calendar days from the date of the Notice to submit a plan”

Priveterra Acquisition Corp. II received a nasdaq noncompliance notice notice regarding market value (rules 5550(b)(2)).

“June 15, 2023, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, based on Nasdaq’s review of the Company’s Market Value of Listed Securities (“MVLS”) for the last 30 consecutive business days, the Company no longer meets the minimum MVLS requirement of $35 million for continued listing of the Company’s Class A common stock, par value $0.0001 per share (“Class A common stock”), on Nasdaq under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”). The Notice has no immediate effect on the listing of the Company’s Class A common stock on Nasdaq and, in accordance”

Owlet, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

“Warrants. On June 16, 2023, the NYSE provided written notice to the Company and publicly announced that NYSE Regulation has determined to commence proceedings to delist the Warrants and that the Warrants are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the NYSE Listed Company Manual. To effect the delisting, the NYSE will apply to the Securities and Exchange Commission to delist the Warrants pending completion of applicable procedures. The Company does not intend to appeal the NYSE’s determination. Trading in the Company’s Class A commo”

Thunder Bridge Capital Partners III Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“June 15, 2023, Thunder Bridge Capital Partners III, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the $35 million minimum requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). The notification received has no immediate effect on the Company’s Nasdaq listing. In accordance with”

Greenlane Holdings, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5450(a)(1)).

“June 22, 2023. On June 22, 2023, the Company received a letter (the “Compliance Notice”) from the Staff stating that because the Class A common stock had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, the Company had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Global Market, as set forth in Rule 5450(a)(1), and that the matter is now closed.”

Greenlane Holdings, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).

“December 16, 2023, Greenlane Holdings, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the 30 consecutive business days preceding the receipt of the Notice, the closing bid price for the Company’s Class A common stock, par value $0.01 per share (the “Class A common stock”), had been below the minimum $1.00 per share required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (“Rule 5450(a)(1)”). The Notice also indicated”

Spark Networks SE received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(b)(1)).

“April 12, 2023, Company received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s stockholders’ equity as reported in its Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2022 (the “Form 10-K”), did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market, which requires that a listed company’s stockholders’ equity be at least $2.5 million. As reported on its Form 10-K, the Company reported stockholders’ deficit of approximately $(6,786,0”

Spark Networks SE received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“m 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s ADSs from listing and registration on The Nasdaq Stock Market. The Company may appeal Staff’s determination to a Hearings Panel, pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. Requests for a hearing and for an extended stay should be submitted electronically through the Nasdaq Listing Center, and must be received no later than 4:00 Eastern Time on June 28, 2023. The fee for a hearing is $20,000. The Company is currently evaluating its options with respec”

Cenntro Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“June 21, 2023, the Company received written notice (the "Notice") from Nasdaq notifying the Company that the Ordinary Shares had not regained compliance with the Minimum Bid Price Requirement. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company is eligible for an additional 180 calendar day period from the date of the receipt of the Notice or until December 18, 2023, to regain compliance with the Minimum Bid Price Requirement. If at any time before December 18, 2023, the bid price of the Company's Ordinary Shares closes at $1.00 per share or more for a minimum of ten consecutive busi”

ALPINE 4 HOLDINGS, INC. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).

“June 22, 2023, Alpine 4 Holdings, Inc., a Delaware corporation (the “Company”), received a notice (the “June 22 Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company had regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of periodic reports. The June 22 Notice stated: "On May 24, 2023, Staff notified the Company that it no longer met the periodic filing requirement for The Nasdaq Stock Market under Listing Rule 5250(c)(1). Based on the June 21, 2023, filing of the Company’s Form 10-Q for the period ended March 31, 2023, Staff has d”

ONCOSEC MEDICAL Inc received a nasdaq delisting notice notice regarding other (rules 5550(b)(1), 5550(a)(2)).

“June 15, 2023, the Chapter 7 bankruptcy trustee (“Trustee”) for OncoSec Medical Incorporated (the “Company”) received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company and the Trustee that the Staff has, in accordance with Listing Rules 5101, 5110(b), and IM-5101-1, determined that the Company’s securities will be delisted from Nasdaq based on the following factors: (i) on June 14, 2023, the Company filed for protection under Chapter 7 of the U.S. Bankruptcy Code (the “Chapter 7 Filing”) and the associ”

MEDICINOVA INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(b)(1)).

“June 15, 2023, MediciNova, Inc. (the “Company”) received a letter (the “Audit Committee Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to Jeff Himawan, Ph.D. not standing for re-election as a Class I director of the Company at the Company’s 2023 annual meeting of stockholders held on June 13, 2023 (the “Annual Meeting”), the Company was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A) (the “Audit Committee Listing Rule”), which requires the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of the Company to be co”

Valuence Merger Corp. I received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“June 14, 2023, Valuence Merger Corp. I (the “Company”), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that since the Company’s aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the “Notice”). The Notice additionally indicates that the Company, pursu”

UTA Acquisition Corp received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“June 14, 2023, UTA Acquisition Corporation (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Listing Rule 5452(b)(C) of the Nasdaq Global Market, which requires the Company to maintain a minimum of $1,000,000 in aggregate market value of its outstanding warrants for continued listing on the Nasdaq Global Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Compa”

Chenghe Acquisition I Co. received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“June 15, 2023, LatAmGrowth SPAC, a Cayman corporation (the “Company”) received a notification letter from the NASDAQ Listing Qualifications (“NASDAQ”) stating the Company was not in compliance with NASDAQ Listing Rule 5452(b)(C), due to its failure to maintain a minimum of $1,000,000 in aggregate market value of its outstanding warrants for continued listing. The NASDAQ notification letter provides the Company 45 calendar days from the date of the notification, or until July 31, 2023, to submit a plan to NASDAQ to regain compliance with the NASDAQ’s continued listing requirements. If the plan”

Pearl Holdings Acquisition Corp received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“June 14, 2023, Pearl Holdings Acquisition Corp (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), with respect to its warrants, indicating that the Company is not in compliance with Listing Rule 5452(b)(C), due to the Company’s failure to maintain the minimum of $1,000,000 in aggregate market value of its outstanding warrants. The Notice is only a notification of deficiency, not of imminent delisting. The Notice states that the Company has until July 29, 2023 to submit a plan to ac”

Moringa Acquisition Corp received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“June 15, 2023, Moringa Acquisition Corp, a Cayman Islands exempted company (the “Company”), received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Listing Rule 5550(b)(2) (the “MVLS Rule”), which requires the Company to have at least $35 million market value of listed securities (the “MVLS”) for continued listing on the Nasdaq Capital Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or tradin”

TriSalus Life Sciences, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“June 14, 2023, MedTech Acquisition Corporation, a Delaware corporation (the “Company”), received a deficiency letter (the “Notice”) of non-compliance from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the $35 million minimum requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). The Notice has no immediate effect on the Company’s Na”

BARFRESH FOOD GROUP INC. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)).

“June 14, 2023, Barfresh Food Group Inc. (the “Company”) received a letter (the “Extension Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that Nasdaq has granted the Company a 180-day extension, until October 30, 2023 (the “Extension Period”), to regain compliance with the Listing Rule 5550(b) (the “Rule”), which requires a minimum $2,500,000 stockholders’ equity, $35,000,000 market value of listed securities, or $500,000 net income from continuing operations. The Extension Notice has no immediate effect on the continued listing s”

Groupon, Inc. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).

“June 21, 2023, Groupon, Inc. (“Groupon” or the “Company”) notified the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not currently in compliance with Nasdaq Listing Rule 5605(c)(2)(A) (the “Listing Rule”), but that it intends to regain compliance within the cure period provided by section (c)(4)(B) of the Listing Rule. The Listing Rule requires the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of the Company to be composed of at least three members, each of whom must meet independence requirements under the Nas”

CAMBER ENERGY, INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).

“June 14, 2023, the Company received a notice from the NYSE American (the “ Notice ”) that the Plan was accepted. The Notice granted the Company until April 12, 2024 (the “ Plan Period ”) to regain compliance with the NYSE American’s continued listing standards. The Notice has no immediate impact on the listing of the Company’s shares of common stock, par value $0.001 per share (the “ Common Stock ”), which will continue to be listed and traded on the NYSE American during the Plan Period, subject to the Company’s compliance with the other listing requirements of the NYSE American. The listing o”

Troika Media Group, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“June 20, 2023, the Nasdaq staff (the “Staff”) notified the Company that the Company had regained compliance with the Minimum Bid Price Rule based on the closing bid price of the Company’s common stock having been at $1.00 per share or greater for 10 consecutive business days. The Staff’s notification indicated that this matter is now closed. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Troika Media Group, Inc. (Registrant) Date: June 21, 2023 By:”

HWH International Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“June 16, 2023, Alset Capital Acquisition Corp. (the “ Company ”) received a letter (the “ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) that, for the previous 30 consecutive business days, the Market Value of Listed Securities (“ MVLS ”) for the Class A Common Stock of the Company, par value $0.0001 per share (“ Class A Common Stock ”), was below the $50 million minimum MVLS requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “ MVLS Rule ”). The Letter is only a notification of deficiency”

Liberty Resources Acquisition Corp. received a nasdaq noncompliance notice notice regarding other (rules 5450(b)(1)(B)).

“June 15, 2023, Liberty Resources Acquisition Corp., a Delaware corporation (the “ Company ”), received a written notice (the “ Public Float Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) notifying the Company that it no longer meets the minimum 1,100,000 publicly held shares required for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5450(b)(1)(B) (the “ Public Float Standard ”). The Company believes that the Public Float Notice may have been issued in error. The Company plans to discuss the Public Float Notice with Nasdaq to get the P”

Revelstone Capital Acquisition Corp. received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“June 14, 2023, Revelstone Capital Acquisition Corp., a Delaware corporation (the “ Company ”) received a notification letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that that it was not in compliance with Nasdaq Listing Rule 5452(b)(C) with respect to its warrants for failing to maintain a minimum of $1,000,000 in aggregate market value of its outstanding warrants which is required by the Nasdaq Global Market. Under the Nasdaq Listing Rules, the Company has 45 calendar days from June 14, 2023, or July 31, 2023, to submi”

CSLM ACQUISITION CORP. received a nasdaq deficiency notice notice regarding other (rules 5452(b)(C)).

“June 13, 2023, Consilium Acquisition Corp. I Ltd. (the “Company”) received a notification from The Nasdaq Stock Market (“Nasdaq”) that it was not in compliance with Nasdaq Listing Rule 5452(b)(C) with respect to its Warrants which failed to maintain a minimum of $1,000,000 in aggregate market value of its outstanding warrants which is required by the Nasdaq Global Market. Under the Nasdaq Listing Rules, the Company has 45 calendar days from June 13, 2023 to submit a plan to regain compliance and if the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the date of”

Target Global Acquisition I Corp. received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that since the Company’s aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the “Notice”). The Notice additionally indicates that the Company, pursuant to the Listing Rules, has 45 calendar days, or until July 30, 2023, to submit a plan to regain”

Chain Bridge I received a nasdaq noncompliance notice notice regarding market value (rules 5452(b)(C)).

“Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that since the Company's aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the “Notice”). The Notice additionally indicates that the Company, pursuant to the Listing Rules, has 45 calendar days, or until July 28, 2023, to submit a plan to regain”

Disruptive Acquisition Corp I received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“June 16, 2023, Disruptive Acquisition Corporation I (the “Company”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was no longer in compliance with Listing Rule 5550(b)(2) (the “MVLS Listing Requirement”) with respect to its Class A ordinary shares (the “Ordinary Shares”), which requires the Company to maintain an aggregate market value of listed securities of at least $35.0 million for continued listing on The Nasdaq Capital Market (the “Notice”). The Notice additionally indicates that the Company has”

Sustainable Development Acquisition I Corp. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2), 5550(b)(2), 5810(c)(3)(c)).

“June 15, 2023, Sustainable Development Acquisition I Corp. (the “ Company ”) received a notification letter (the “ Notification Letter ”) from The Nasdaq Stock Market, LLC (“ Nasdaq ”) that it is not in compliance with the minimum Market Value of Listed Securities (the “ MVLS ”) set forth in Nasdaq Listing Rule 5450(b)(2) for continued listing on Nasdaq. Nasdaq Listing Rule 5550(b)(2) requires listed securities to maintain a MVLS of $35,000,000, and Nasdaq Listing Rule 5810(c)(3)(c) provides that a failure to meet the minimum MVLS requirement exists if the deficiency continues for a period of”

Prospector Capital Corp. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“June 16, 2023, Prospector Capital Corp. (the “Company”) received a letter from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “Market Value Standard”). The Notice is only a notification of deficiency and not a notification of imminent delisting. The notice has no immediate effect on t”

Appreciate Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“nued Listing Rule or Standard; Transfer of Listing On June 13, 2023, Appreciate Holdings, Inc. (“Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1) (the “Rule”) because the closing bid price for the last 32 consecutive business days was lower than $1.00. The Rule requires listed companies to maintain a minimum bid price of $1.00. The Notice has no immediate effect on the listing or trading of the Company’s securities. The Company has”

Janux Therapeutics, Inc. received a nasdaq noncompliance notice notice regarding board independence (rules 5605(b)(1)).

“June 16, 2023 acknowledging the Company’s non-compliance with Listing Rule 5605(b)(1). The letter from Nasdaq further provided that, consistent with Listing Rule 5605(b)(1)(A), Nasdaq will provide the Company a cure period in order to regain compliance with Listing Rule 5605(b)(1). The cure period will end on the earlier of (i) the Company’s next annual meeting of stockholders or (ii) June 14, 2024 (unless such next annual meeting is held prior to December 11, 2023, in which case the cure period will end on December 11, 2023). The Board is evaluating options to achieve compliance within the cu”

Digital Media Solutions, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

“de on the NYSE under the symbol “DMS WS” (the “Warrants”), from the NYSE and that trading in the Warrants on the NYSE would be suspended immediately. The Staff has determined that the Warrants are no longer suitable for listing on the NYSE based on “abnormally low” price levels, pursuant to Section 802.01D of the NYSE Listed Company Manual. Trading in the Company’s Class A Common Stock and units on the NYSE will continue.”

Senmiao Technology Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“June 15, 2023, Senmiao Technology Limited (the “Company”) received a deficiency notice from The Nasdaq Stock Market (“Nasdaq”) informing the Company that its common stock, par value $0.0001 per share (the “Common Stock”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 30 consecutive business days prior to the date of the notice from Nasdaq. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasdaq Capital Mar”

ADDENTAX GROUP CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“June 15, 2023, from the Listings Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share of its common stock was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Nasdaq notification letter does not result in the immediate delisting of the Company’s common stock, and the shares will continue to trade uninterrupted under the symbol “ATXG.” Pursuant to Nasdaq”

Aclarion, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“June 15, 2023, the Nasdaq staff (the “Staff”) notified the Company that the Company had regained compliance with the Minimum Bid Price Requirement based on the closing bid price of the Company’s common stock having been at $1.00 per share or greater for the 10 consecutive business days from June 1, 2023 to June 14, 2023. The Staff’s notification indicated that this matter is now closed. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ACLARION, INC”

Freedom Holding Corp. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“June 15, 2023, Freedom Holding Corp. (the “Company”) received a letter (the “Non-Compliance Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to have timely filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “Fiscal 2023 10-K”). The Non-Compliance Letter provides the Company with 60 calendar days, or until August 14, 2023, to submit to Nasdaq a plan to regain compliance in accordance with Nasdaq’s listing requireme”

Alternus Clean Energy, Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5452(b)(C)).

“June 13, 2023, Clean Earth Acquisitions Corp. (the “Company”) received a letter (the “Notification Letter”) from the Listing Qualifications Department of NASDAQ Stock Market (the “Staff”) notifying the Company that the $575,000.00 aggregate market value of the Company’s outstanding public warrants, ticker symbol CLINW, as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023, was below the minimum aggregate market value of $1,000,000.00 required for continued listing on the NASDAQ Capital Market as set forth in NASDAQ listing rule 5452(b)(C) (the “Rule”).”

Genesis Growth Tech Acquisition Corp. received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“June 13, 2023, Genesis Growth Tech Acquisition Corp. (the “ Company ”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating the Company was not in compliance with Nasdaq Listing Rule 5452(b)(C), as a result of the aggregate market value of the Company’s outstanding warrants falling below the required minimum of $1,000,000 in aggregate market value on June 12, 2023 and for failing to meet the continued Nasdaq listing requirements under alternative standards. The Nasdaq notification letter has no immediate effect on the lis”

Canton Strategic Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“June 12, 2023, Hillstream BioPharma, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) indicating that the bid price for the Company’s common stock (the “Common Stock”), for the last 30 consecutive business days, had closed below the minimum $1.00 per share and, as a result, the Company is not in compliance with the $1.00 minimum bid price requirement for the continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2). The Notice has no effect at this time of the Common Stock, which continues to trade on”

Jet.AI Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“June 14, 2023, Oxbridge Acquisition Corp. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Listing Rule 5550(b)(2) (the “Minimum Market Value of Listed Securities” or “MVLS”), which requires the Company to have at least $35 million market value of listed securities for continued listing on the NASDAQ Capital Market. The Notice similarly indicates that the Company, pursuant to the Listing Rules, has a compliance period of 180 calendar days in which it can”

Chenghe Acquisition Co. received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that since the Company’s aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in the Nasdaq Listing Rule 5452(b)(C), which requires the Company to”

LF Capital Acquisition Corp. II received a nasdaq deficiency notice notice regarding market value (rules 5452(b)(C)).

“alifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that since the Company’s aggregate market value of its outstanding warrants was less than $1.0 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1.0 million (the “Notice”). The Notice additionally indicates that the Company, pursuant to the Listing Rules, has 45 calendar days, or until July 31, 2023, to submit a plan to regai”